At the end of the webinar you will be able to:

  • Explain the difference between reproductive and developmental toxicity
  • Outline the ways in which chemical exposure may interfere with the normal reproductive and developmental processes
  • Describe the key elements of the male and female reproductive system
  • Outline the role hormones play in the reproductive process (endocrine system)
  • Define the terms endocrine disruptor, endocrine active substance, possible endocrine disruptor
  • Explain the criteria which are currently used for the identification of endocrine disruptors
  • Explain the process of fertilisation and the difference between embryonic and foetal stages
  • Explain why organogenesis is such a critical time period in the developmental process
  • Explain the difference between teratogen, congenital malformation and teratology and what is meant by maternal mediated effects
  • Outline how a thorough introduction to reproductive and developmental toxicity,and the current approach which is taken in their assessment (QSAR, human evidence, in vitro, in vivo studies - one generation, two generation, extended one generation reproductive toxicity studies and prenatal developmental toxicity studies)
  • Explain what is meant by delayed ossification, wavy ribs and malformations

Training Resources for this session includes:

  • Training handbook, complementing the webinar and including practice questions and answers.
  • Copy of all slides used during the training
  • Downloadable recording of the training event itself, for your personal review

Who the webinar is for:

This webinar is ideal for anyone who would benefit from an improved understanding of reproductive and developmental toxicity, but has no formal training as a toxicologist. In particular for business managers involved in SIEF/consortia discussions, global regulatory compliance experts, hazard communication (CLP/GHS) and SDS, etc